NOVOMATIC Risks and Prospects: What Matters for the Group

NOVOMATIC's risks at a glance

These are different kinds of exposure with different evidential standards. The table is a dated register, not a prediction that each risk will turn into a financial loss. For the group's business structure, see our NOVOMATIC overview.

Casinos Austria and the CASAG-Sidlo proceedings

Casinos Austria appears in two separate strands of NOVOMATIC's history: changes to shareholdings in the casino business and allegations associated with the so-called CASAG-Sidlo investigation. Treating the two as interchangeable would produce a misleading account of both corporate ownership and legal exposure.

NOVOMATIC previously held an interest in Casinos Austria and later sold its 17.19% stake to Sazka. That transaction belongs to an earlier ownership history. It does not establish NOVOMATIC's current stake, nor does it resolve questions arising from subsequent investigations. The wider chronology, rather than a presumed present-day ownership link, belongs in our NOVOMATIC history.

On 27 February 2026, NOVOMATIC published a statement concerning the CASAG-Sidlo matter. The company said that, after a lengthy investigation, a demand for prosecution had been filed concerning a remaining allegation. It disputed the basis for that step and rejected the allegations. NOVOMATIC also described what it regarded as the proposed discontinuation of other matters. Those are claims made by the company about the process, not independently verified findings by the court.

The distinction between an allegation, a prosecution request and a judgment is fundamental. An allegation concerns conduct being examined; a formal procedural step may bring a dispute before a court; neither, by itself, demonstrates guilt. Equally, a company's denial is not proof that the allegations have been judicially rejected. The reporting available for this article does not establish the final disposition of the remaining matter from an independent Austrian court or prosecutorial record as at 12 November 2026.

For NOVOMATIC's outlook, this creates a narrower, more defensible conclusion than the phrase 'NOVOMATIC scandal' suggests. A continuing or unresolved legal question can impose advice costs, distract executives and affect counterparties' assessments even before any outcome. Conversely, an authoritative judgment or documented discontinuation could remove some uncertainty. Neither scenario should be presented as having happened until the underlying decision is available.

The relevant watchpoint is a dated judicial document identifying the parties, procedural stage and decision.

UK regulation: what happened at Greentube Alderney

The clearest directly documented British regulatory exposure concerns Greentube Alderney Limited, an operating company associated with the Admiral Casino online business. The UK Gambling Commission's public register identifies Greentube Alderney under account 39050. It is important to name this licensee: a regulatory finding about Greentube Alderney is not automatically a finding against every NOVOMATIC company, technology supplier or land-based venue.

The Commission published two distinct actions:

Neither event should be silently translated into a criminal fine. The 2025 UKGC register describes a regulatory review and a settlement, including a payment in lieu of a financial penalty, divestment and Commission costs. That legal form matters when assessing the severity and implications of enforcement.

For 2025, the regulator described deficiencies in money-laundering controls and customer interactions. The repeat occurrence raises the question of whether remediation remains effective after earlier intervention.

This history does not mean the operator was stripped of its British licence. On 12 November 2026, the UKGC public-register page reviewed for this article showed active remote permissions for casino, bingo, gambling software and certain betting activities. That is a dated register observation, not a guarantee of future licensing or a blanket endorsement of every operation bearing the Admiral name.

The commercial implications extend beyond settlement payments. Effective financial-crime controls, customer monitoring, staff training and independent assurance require ongoing expenditure. Weak systems risk further intervention, while sustained remediation can reduce the likelihood of repetition. When assessing NOVOMATIC, the useful question is whether a specific regulated subsidiary has demonstrably strengthened its controls, not whether the entire corporate family can be labelled 'safe' or 'unsafe' by association.

Our NOVOMATIC markets and licences guide covers the broader jurisdiction-by-jurisdiction picture; the relevant licence and legal entity must always be checked individually.

Trademark and intellectual-property exposure

For a gaming technology business, rights to product names, features and designs affect what can be launched and where. US Trademark Trial and Appeal Board (TTAB) records offer a useful illustration, but they also show why filing a dispute is not the same as winning it.

In October 2026, Mattel, Inc. opposed two NOVOMATIC trademark applications involving XTENSION LINK MAGIC BALL and XTENSION LINK MAGICBALL. The reviewed TTAB records show oppositions 91310965 and 91310963, filed on 7 October 2026, with a pending status in the available docket snapshots. These are proceedings concerning applications, not court findings that NOVOMATIC infringed Mattel's rights.

The record is more mixed for Aristocrat Interactive. Oppositions over MAGIC WIN EXPLOSION and MAGIC WIN BOOST were filed in June and July 2026. Crucially, TTAB docket 91309276 was terminated on 24 August 2026 after the relevant application was withdrawn on 21 August, with the opposition dismissed without prejudice. A separate MAGIC WIN EXPLOSION opposition, 91309297, was terminated on 25 August 2026 following an application withdrawal and dismissal without prejudice.

Docket 91308229 likewise shows termination on 21 August 2026. These three proceedings must not be described as continuing litigation. The records reviewed do not establish the individual disposition of 91308230; a related extension-of-time entry does not supply that outcome.

Withdrawal and dismissal without prejudice do not establish infringement. Contested names can require product renaming, delay clearance or incur legal expense, but docket entries do not quantify a loss.

Acquisitions, execution and Ainsworth

Deals present a different kind of uncertainty. NOVOMATIC's proposed acquisition of the shares it did not already own in Ainsworth Game Technology Limited was intended to increase its ownership of an ASX-listed manufacturer. The agreement and offer were public corporate transactions, not a private NOVOMATIC share-market listing.

The subsequent official sequence is decisive. Ainsworth's 11 February 2026 ASX release states that NOVOMATIC's off-market offer closed on 6 February 2026, the relevant scheme had not become effective by the end date and the Transaction Implementation Deed was terminated. Therefore, a description of Ainsworth as 100% acquired by NOVOMATIC would be wrong for this transaction.

That failure to complete the buyout did not, by itself, eliminate NOVOMATIC's existing majority holding. Ainsworth remained a distinct listed company whose reporting is denominated in Australian dollars. The group-level revenue reported by NOVOMATIC and the separate Ainsworth results cannot simply be added together without addressing the consolidation boundary.

The case illustrates execution risk: even a transaction backed by a strategic rationale can depend on shareholder participation, timing, procedural conditions and competing interests. A proposed acquisition can consume management time and professional fees yet fail to deliver the intended simplification or synergies. For analysts, the better question is what alternative strategy remains once a buyout ends, not whether the proposal was a 'win' or 'loss' in isolation.

Read our NOVOMATIC capital and Ainsworth analysis for the ownership and share-market boundaries. Its quoted share figures must be dated to the relevant Ainsworth disclosure, not presented as a live share price for NOVOMATIC AG.

Operating and financial pressure points

NOVOMATIC combines Gaming Technology (supplying equipment, content and associated systems) with Gaming Operations, where companies run venues or remote services. This diversification creates several revenue channels, but it also means very different obligations sit behind the group name. Product approvals and intellectual-property clearance matter to a supplier; local licensing, customer protection and anti-money-laundering controls matter directly to an operator.

The 2025 company report places the scale in perspective. NOVOMATIC reported €3,616.8 million of consolidated revenue for 2025, compared with the report's €3,706.7 million comparative figure for 2024: a 2.4% decline. The company attributed the decline primarily to divestments, including the sale of Austrian operating companies. It also described growth in UK activities and Greentube's online business. These are management's descriptions of its performance, not proof that every market or segment improved.

That mix matters. Disposing of a business can reduce total revenue while making the remaining portfolio more focused. Conversely, acquiring operators or technology businesses can increase gross scale without establishing that the purchase was profitable after integration costs. A credible assessment therefore looks at cash conversion, operating profitability and returns on deployed capital alongside the headline sales figure. The audited consolidated statements provide the relevant profit and cash-flow measures.

The NOVOMATIC financial results analysis considers those measures in detail. Here, the central exposure is whether the group can maintain compliant, cash-generative operations across markets while investing in products, employees and acquisitions. A positive top-line announcement is not sufficient evidence on its own.

Prospects: conditions for a stronger or weaker outcome

NOVOMATIC's technology business reaches corporate customers, while its operations provide local market presence. Both depend on regulation, execution and financial discipline. The cases below are qualitative editorial scenarios, not company guidance, forecasts or investment recommendations.

Regulatory resilience comes first. The UKGC cases show that an operator can face enforcement while remaining licensed. Durable improvement requires demonstrable controls, adapted to each jurisdiction.

Product economics are the second test. NOVOMATIC's development footprint offers opportunities, but machines and digital content still need technical approvals, brand clearance and distribution. Delays can change innovation returns; a withdrawn trademark application may mean renaming, not catastrophic loss.

Capital allocation is the third test. Ainsworth illustrates why an announced proposal is not a completed asset. Deals require satisfied closing conditions and disciplined financing; acquisition-led revenue is not necessarily value creation.

Transparency is the fourth test. Private NOVOMATIC AG has no directly traded share price. Group reports, regulator registers and Ainsworth's ASX disclosures cover different entities; Ainsworth's interim accounts cannot establish the parent's 2026 performance.

The best outcome would combine sustained regulatory compliance, successful product deployment and cash-generative expansion. The central case is a business that continues trading and investing while managing normal sector constraints and specific unresolved issues. The weaker case depends on an actual deterioration in controls, legal outcomes or financial execution: not on the mere existence of an old headline.

My assessment and what to monitor next

NOVOMATIC has material advantages in its combined technology-and-operations model, but breadth also multiplies the number of regulators, contractual relationships and intellectual-property decisions that matter. The UK subsidiary's enforcement record is established; its active licence position is a separate, dated fact. The Ainsworth full-buyout proposal ended; NOVOMATIC's pre-existing majority interest did not thereby vanish. US trademark proceedings have differing statuses, including documented terminations. The Austrian CASAG-Sidlo question must be discussed with the company's denial and an explicit limit on independently verified court outcomes.

The next evidence worth watching is specific: a verifiable Austrian judicial update; new UKGC action or confirmation of sustained remediation; status changes in each US trademark docket; formal Ainsworth corporate announcements; and comparable group financial statements. I would favour those dated documents over recycled allegations or deal headlines. To understand which executives and owners ultimately oversee these decisions, see the NOVOMATIC ownership and management guide.